Insulet Launches Omnipod 5 Automated Insulin Delivery System In Spain

(RTTNews) - Insulet Corporation (PODD) on Monday said it has launched its Omnipod 5 Automated Insulin Delivery System and Omnipod Discover data management platform in Spain.

Omnipod 5, a tubeless automated insulin delivery system, is indicated in Spain for people aged two years and older with type 1 diabetes and is compatible with the Abbott FreeStyle Libre 2 Plus and Dexcom G7 continuous glucose monitoring systems.

Spain becomes the 26th country where Insulet sells Omnipod products and the 20th market where Omnipod 5 is available. The company said it has launched Omnipod 5 in 15 countries over the past 18 months as part of its international expansion strategy.

Insulet is also introducing Omnipod Discover in Spain, a web-based data analytics and reporting platform designed for Omnipod 5 users, caregivers and healthcare providers. The platform was first launched in five Middle Eastern countries earlier this year and is expected to expand to additional Omnipod 5 markets over the next year.

Spain has more than 4.6 million adults with diabetes, including about 189,000 people with type 1 diabetes and over 18,500 children and adolescents who require insulin treatment.

Insulet shares closed at $164.48 on Thursday, up 2.94%.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

This data feed is not available at this time.